Research output per year
Research output per year
Personal profile
Research
Ansvarlig på modermærkekræft behandlingen i afdelingen samt for melanom forskningsdatabasen for Århus.
Areas of expertise
- Oncology
- Melanoma
Fingerprint
Dive into the research topics where Henrik Schmidt is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Cardiotoxicity in patients with metastatic melanoma treated with BRAF/MEK inhibitors: a real-world analysis of incidence, risk factors, and reversibility
Oddershede, J. K., Meklenborg, I. K., Bastholt, L., Guldbrandt, L. M., Schmidt, H. & Friis, R. B., 13 Apr 2025, In: Acta oncologica (Stockholm, Sweden). 64, p. 507-515 9 p.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access -
Impact of assessment-to-treatment interval and metastatic biopsy site on the predictive value of PD-L1 expression at the 1 % cut-off level in melanoma
Vestergaard, C. D., Donia, M., Madsen, K., Schmidt, H., Luczak, A. A., Bastholt, L., Ellebaek, E. & Svane, I. M., 15 May 2025, In: European Journal of Cancer. 221, 115402.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access -
Long-term clinical outcome of patients with metastatic melanoma and initial stable disease during anti-PD-1 checkpoint inhibitor immunotherapy with pembrolizumab
Noringriis, I. M., Donia, M., Madsen, K., Schmidt, H., Haslund, C. A., Bastholt, L., Svane, I. M. & Ellebaek, E., 2025, (E-pub / Early view) In: British Journal of Cancer.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access -
Risk of and Mortality After Acute Kidney Injury Following Cancer Treatment: A Cohort Study
Munch, P. V., Nørgaard, M., Jensen, S. K., Birn, H., Schmidt, H. & Christiansen, C. F., Feb 2025, In: Cancer medicine. 14, 3, e70646.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access -
Survival improvements in patients with melanoma brain metastases and leptomeningeal disease in the modern era: Insights from a nationwide study (2015–2022)
Pedersen, S., Johansen, E. L., Højholt, K. L., Pedersen, M. W., Mogensen, A. M., Petersen, S. K., Haslund, C. A., Donia, M., Schmidt, H., Bastholt, L., Friis, R., Svane, I. M. & Ellebaek, E., 25 Feb 2025, In: European Journal of Cancer. 217, 115253.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access3 Citations (Scopus)
-
Fagudvalg under medicinrådet
Schmidt, H. (Member)
2020 → …Activity: Presentations, memberships, employment, ownership and other activities › Member of committee, council or board
-
Proliferation indices of PHH3/MART1 double stains are strong independent predictors of clinical outcome in primary cutaneous melanoma
Steiniche, T. (Lecturer), Nielsen, P. S. (Other), Jensen, T. Ø. (Other), Schmidt, H. (Other) & Riber-Hansen, R. (Other)
9 Sept 2012Activity: Presentations, memberships, employment, ownership and other activities › Lecture and oral contribution